Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PM647a in Alpha-1 Antitrypsin Deficiency
NCT07887347Phase 2Not yet recruiting
- Sponsor
- Prime Medicine, Inc.
- Start
- Oct 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of PM647 in alpha-1 antitrypsin deficiency (AATD), sponsored by Prime Medicine, Inc.. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
PM647
03
Conditions
alpha-1 antitrypsin deficiency (AATD)
Beyond the preview
Go deeper on NCT07887347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07887347.